{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T01:29:40Z","timestamp":1711157380553},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,22]]},"DOI":"10.7759\/cureus.56701","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T12:04:46Z","timestamp":1711109086000},"source":"Crossref","is-referenced-by-count":0,"title":["Agranulocytosis Associated With Psychiatric Polypharmacy: Lessons Learned From a Clinical Case"],"prefix":"10.7759","author":[{"given":"Nicole Ann E","family":"Villa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragos G","family":"Pausescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo D","family":"Espiridion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e328333e132","article-title":"An update of evidence-based treatment of bipolar depression: where do we stand?","volume":"23","author":"Fountoulakis KN","year":"2010","unstructured":"Fountoulakis KN. An update of evidence-based treatment of bipolar depression: where do we stand?. Curr Opin Psychiatry. 2010, 23:19-24. 10.1097\/YCO.0b013e328333e132","journal-title":"Curr Opin Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201700260","article-title":"Prevalence, time trends, and utilization patterns of psychotropic polypharmacy among pediatric Medicaid beneficiaries, 1999-2010","volume":"69","author":"Soria Saucedo R","year":"2018","unstructured":"Soria Saucedo R, Liu X, Hincapie-Castillo JM, Zambrano D, Bussing R, Winterstein AG. Prevalence, time trends, and utilization patterns of psychotropic polypharmacy among pediatric Medicaid beneficiaries, 1999-2010. Psychiatr Serv. 2018, 69:919-26. 10.1176\/appi.ps.201700260","journal-title":"Psychiatr Serv"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.11919\/j.issn.1002-0829.214152","article-title":"When is antidepressant polypharmacy appropriate in the treatment of depression?","volume":"26","author":"Si T","year":"2014","unstructured":"Si T, Wang P. When is antidepressant polypharmacy appropriate in the treatment of depression?. Shanghai Arch Psychiatry. 2014, 26:357-9. 10.11919\/j.issn.1002-0829.214152","journal-title":"Shanghai Arch Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13312","article-title":"Polypharmacy as maintenance treatment in bipolar illness: a systematic review","volume":"144","author":"Amerio A","year":"2021","unstructured":"Amerio A, Russo D, Miletto N, et al.. Polypharmacy as maintenance treatment in bipolar illness: a systematic review. Acta Psychiatr Scand. 2021, 144:259-76. 10.1111\/acps.13312","journal-title":"Acta Psychiatr Scand"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3109\/10401239309148969","article-title":"Rational polypharmacy in the treatment of mood disorders","volume":"5","author":"Reus VI","year":"1993","unstructured":"Reus VI. Rational polypharmacy in the treatment of mood disorders. Ann Clin Psychiatry. 1993, 5:91-100. 10.3109\/10401239309148969","journal-title":"Ann Clin Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.08m04212","article-title":"Polypharmacy in children and adolescents treated for major depressive disorder: a claims database study","volume":"70","author":"McIntyre RS","year":"2009","unstructured":"McIntyre RS, Jerrell JM. Polypharmacy in children and adolescents treated for major depressive disorder: a claims database study. J Clin Psychiatry. 2009, 70:240-6. 10.4088\/jcp.08m04212","journal-title":"J Clin Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1229.104497","article-title":"Polypharmacy in psychiatry: a review","volume":"11","author":"Kukreja S","year":"2013","unstructured":"Kukreja S, Kalra G, Shah N, Shrivastava A. Polypharmacy in psychiatry: a review. Mens Sana Monogr. 2013, 11:82-99. 10.4103\/0973-1229.104497","journal-title":"Mens Sana Monogr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.150.4.501","article-title":"A comparative hospital survey of psychotropic drug prescribing","volume":"150","author":"Muijen M","year":"1987","unstructured":"Muijen M, Silverstone T. A comparative hospital survey of psychotropic drug prescribing. Br J Psychiatry. 1987, 150:501-4. 10.1192\/bjp.150.4.501","journal-title":"Br J Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199309060-00005","article-title":"Adverse effects of antipsychotic drugs","volume":"9","author":"Malhotra AK","year":"1993","unstructured":"Malhotra AK, Litman RE, Pickar D. Adverse effects of antipsychotic drugs. Drug Saf. 1993, 9:429-36. 10.2165\/00002018-199309060-00005","journal-title":"Drug Saf"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3109\/10401239409149012","article-title":"Bupropion\/nortriptyline combination for refractory depression","volume":"6","author":"Apter JT","year":"1994","unstructured":"Apter JT, Kushner SF, Woolfolk RL. Bupropion\/nortriptyline combination for refractory depression. Ann Clin Psychiatry. 1994, 6:255-8. 10.3109\/10401239409149012","journal-title":"Ann Clin Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4306\/pi.2008.5.2.121","article-title":"Three cases of reversible agranulocytosis after treatment with lamotrigine","volume":"5","author":"Ahn YM","year":"2008","unstructured":"Ahn YM, Kim K, Kim YS. Three cases of reversible agranulocytosis after treatment with lamotrigine. Psychiatry Investig. 2008, 5:121-3. 10.4306\/pi.2008.5.2.121","journal-title":"Psychiatry Investig"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.encep.2008.04.003","article-title":"Chlorpromazine-induced agranulocytosis: a case report [Article in French]","volume":"35","author":"Stephan F","year":"2009","unstructured":"Stephan F, Podlipski MA, Kerleau JM, Petit M, Guillin O. Chlorpromazine-induced agranulocytosis: a case report [Article in French]. Encephale. 2009, 35:173-5. 10.1016\/j.encep.2008.04.003","journal-title":"Encephale"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2018-0188","article-title":"Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspective","volume":"20","author":"Legge SE","year":"2019","unstructured":"Legge SE, Walters JT. Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspective. Pharmacogenomics. 2019, 20:279-90. 10.2217\/pgs-2018-0188","journal-title":"Pharmacogenomics"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2016.03.68","article-title":"Psychotropic medication use in hospitalized patients with borderline personality disorder","volume":"6","author":"Moeller KE","year":"2016","unstructured":"Moeller KE, Din A, Wolfe M, Holmes G. Psychotropic medication use in hospitalized patients with borderline personality disorder. Ment Health Clin. 2016, 6:68-74. 10.9740\/mhc.2016.03.68","journal-title":"Ment Health Clin"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2009.175","article-title":"National trends in psychotropic medication polypharmacy in office-based psychiatry","volume":"67","author":"Mojtabai R","year":"2010","unstructured":"Mojtabai R, Olfson M. National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry. 2010, 67:26-36. 10.1001\/archgenpsychiatry.2009.175","journal-title":"Arch Gen Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.11919\/j.issn.1002-0829.214182","article-title":"Provide optimized antidepressant monotherapy with multiple drugs before considering antidepressant polypharmacy","volume":"26","author":"Saah T","year":"2014","unstructured":"Saah T, Garlow SJ, Rapaport MH. Provide optimized antidepressant monotherapy with multiple drugs before considering antidepressant polypharmacy. Shanghai Arch Psychiatry. 2014, 26:360-2. 10.11919\/j.issn.1002-0829.214182","journal-title":"Shanghai Arch Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15238","article-title":"The use of clozapine in the serious mental illness patients enrolled in an assertive community treatment program","volume":"13","author":"Yee MR","year":"2021","unstructured":"Yee MR, Espiridon E, Oladunjoye AO, Millsaps U, Harvey N, Vora AH. The use of clozapine in the serious mental illness patients enrolled in an assertive community treatment program. Cureus. 2021, 13:e15238. 10.7759\/cureus.15238","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/hup.917","article-title":"Haematological toxicity of drugs used in psychiatry","volume":"23","author":"Flanagan RJ","year":"2008","unstructured":"Flanagan RJ, Dunk L. Haematological toxicity of drugs used in psychiatry. Hum Psychopharmacol. 2008, 23:27-41. 10.1002\/hup.917","journal-title":"Hum Psychopharmacol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199707020-00005","article-title":"Mechanism of clozapine-induced agranulocytosis : current status of research and implications for drug development","volume":"7","author":"Pirmohamed M","year":"1997","unstructured":"Pirmohamed M, Park K. Mechanism of clozapine-induced agranulocytosis : current status of research and implications for drug development. CNS Drugs. 1997, 7:139-58. 10.2165\/00023210-199707020-00005","journal-title":"CNS Drugs"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1969.03160100052013","article-title":"Agranulocytosis induced by certain phenothiazine derivatives","volume":"208","author":"Pisciotta AV","year":"1969","unstructured":"Pisciotta AV. Agranulocytosis induced by certain phenothiazine derivatives. JAMA. 1969, 208:1862-8.","journal-title":"JAMA"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/216997-agranulocytosis-associated-with-psychiatric-polypharmacy-lessons-learned-from-a-clinical-case","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T12:04:55Z","timestamp":1711109095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/216997-agranulocytosis-associated-with-psychiatric-polypharmacy-lessons-learned-from-a-clinical-case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.56701","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,22]]}}}